Items where Author is "Ruegg, S."

2012

Hardmeier, M. and Zimmermann, R. and Ruegg, S. and Pfluger, M. and Deuster, S. and Suter, K. and Donzelli, M. and Drewe, J. and Krahenbuhl, S. and Fuhr, P. and Haschke, M.. (2012) Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers. Clinical pharmacology and therapeutics, Vol. 91, H. 5. pp. 856-862.

Rejdak, K. and Kuhle, J. and Ruegg, S. and Lindberg, R. L. and Petzold, A. and Sulejczak, D. and Papuc, E. and Rejdak, R. and Stelmasiak, Z. and Grieb, P.. (2012) Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury. Epilepsia, Vol. 53, H. 5. pp. 922-927.

2011

Sutter, R. and Tschudin-Sutter S., and Grize, L. and Widmer, A. F. and Marsch, S. and Ruegg, S.. (2011) Acute phase proteins and white blood cell levels for prediction of infectious complications in status epilepticus. Critical care, Vol. 15, H. 6 , R274.

2008

Mehling, M. and Drechsler, H. and Kuhle, J. and Hardmeier, M. and Doerries, R. and Ruegg, S. and Gass, A.. (2008) Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement. Journal of neurovirology, Vol. 14, H. 1. pp. 78-84.

Bodmer, M. and Link, B. and Grignaschi, N. and Kummer, O. and Ruegg, S. and Haschke, M. and Krähenbühl, S.. (2008) Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam. Therapeutic drug monitoringNew York : Raven Press, Vol. 30, H. 1. pp. 120-124.